Clinical trial
A Randomized, Blinded Non-inferiority Trial on the Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines in Kenya and Uganda
NCT02991495 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Blinded Non-inferiority Trial on the Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines in Kenya and Uganda
- Lead sponsor
- Epicentre
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 6, 2017
- Completion date
- December 31, 2021
- Enrollment
- 1,630 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.